Agios Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
AGIO
CUSIP
00847X104
All holders as of
Q4 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 19 714 k $20.8 M
2023 Q4 183 58.4 M $1.30 B
2023 Q3 160 57.4 M $1.42 B
2023 Q2 165 57.5 M $1.63 B
2023 Q1 176 57.1 M $1.31 B
2022 Q4 176 60.9 M $1.71 B
2022 Q3 187 56.6 M $1.60 B
2022 Q2 169 57.5 M $1.27 B
2022 Q1 181 58.5 M $1.70 B
2021 Q4 180 57.8 M $1.90 B
2021 Q3 176 59.8 M $2.76 B
2021 Q2 201 64.8 M $3.57 B
2021 Q1 191 64.2 M $3.31 B
2020 Q4 229 64.5 M $2.80 B
2020 Q3 228 64.9 M $2.27 B
2020 Q2 236 67.0 M $3.58 B
2020 Q1 224 68.6 M $2.44 B
2019 Q4 223 68.9 M $3.29 B
2019 Q3 211 62.3 M $2.02 B
2019 Q2 213 60.6 M $3.02 B
2019 Q1 223 59.6 M $4.02 B
2018 Q4 217 58.0 M $2.68 B
2018 Q3 231 57.0 M $4.39 B
2018 Q2 238 54.9 M $4.63 B
2018 Q1 216 55.7 M $4.55 B
2017 Q4 193 47.0 M $2.69 B
2017 Q3 186 46.1 M $3.07 B
2017 Q2 183 46.2 M $2.37 B
2017 Q1 169 41.1 M $2.40 B
2016 Q4 176 39.1 M $1.63 B
2016 Q3 177 37.9 M $2.00 B
2016 Q2 166 34.1 M $1.43 B
2016 Q1 168 33.8 M $1.37 B
2015 Q4 160 33.2 M $2.15 B
2015 Q3 160 31.5 M $2.22 B
2015 Q2 169 30.1 M $3.35 B
2015 Q1 158 28.0 M $2.64 B
2014 Q4 155 27.7 M $3.10 B
2014 Q3 125 24.5 M $1.50 B
2014 Q2 105 24.9 M $1.14 B
2014 Q1 76 20.5 M $804 M